Dabigatrans-safety-efficacy-confirmed-in-VTE-children

Dabigatran ’s safety and efficacy established for management of VTE in children First studies to assess treatment and prevention of recurrent venous thromboembolism (VTE) with dabigatran etexilate in children  The Phase IIb/III DIVERSITY study demonstrated that the efficacy and safety profile of dabigatran was comparable to standard of care (SOC) for the treatment of children with acute VTE1A second Phase III study reinforced the safety profile in children with persistent VTE risk factors receiving dabigatran for prevention of recurrent VTE2   
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news